This 2019 update on medications to treat opioid use disorder and opioid withdrawal provides information about extended release formulations of buprenorphine, reviews evidence for the effectiveness of lofexidene to treat withdrawal symptoms, and also includes a table with comparative costs of opioid use disorder pharmacological therapies.
Funding Source: Oregon State University College of Pharmacy, Oregon Health Authority
Update on Medications Used to Manage Opioid Use Disorder and Opioid Withdrawal
A 2019 update on medications to treat opioid use disorder and opioid withdrawal from the Oregon State Drug Review.